R-PHARM US announces the acquisition of IXEMPRA (ixabepilone) from Bristol-Myers Squibb (NYSE: BMY). IXEMPRA received marketing approval from the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE